Bimekizumab
Product Specifications
CAS Number
1418205-77-2
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
>99.99%
Bioactivity
Bimekizumab is a humanised monoclonal antibody targeting IL17A/IL17F, capable of reducing IL17A/IL17F levels and blocking inflammation-driven osteoblast differentiation. It is applicable for investigating psoriasis and arthritis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2038-100 1x 100 µL
Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/2038), 0.2mg/mL
Sign In for Pricing
View Details 
